Key result
Anticoagulation remains the cornerstone treatment for coronary sinus thrombosis, reserving thrombectomy for severe cases.
Why the study?
Coronary sinus thrombosis is a rare, severe, and underrecognized disease with non-specific symptoms, rapid progression, and high mortality.
This review highlights the importance of early recognition and multimodal imaging in diagnosing coronary sinus thrombosis, emphasizing anticoagulation as the primary treatment.
Clinicians should consider insidious CST in atypical cases; review leaves open optimal management of partial thrombi.
Coronary sinus thrombosis (CST) is a rare and severe disease that remains underrecognized in clinical practice. Most documented cases fall within the acute category, with non-specific symptoms, rapid progression, and a high mortality rate. In contrast, some cases follow an insidious course, leading to the formation of partial or incomplete thrombi that may not cause immediate death but can progress to severe complications over time. This review study the pathophysiology, clinical presentations, diagnostic challenges, and the association with persistent left superior vena cava (PLSVC), emphasizing the utility of imaging modalities such as Echocardiography, Computed Tomography, Magnetic Resonance Imaging and Venography. For management, anticoagulation remains the cornerstone of treatment for CST, with surgical thrombectomy reserved for severe or refractory cases. Post-treatment follow-up is highlighted as essential for monitoring recurrence and managing complications. In brief, the aim of this review is to enhance the understanding of CST and improve clinical outcomes through early recognition, tailored interventions, and multidisciplinary care.
No takes yet. Share an insight, caveat, or question.
Chenlong Yi (2025) conducted a review in Coronary sinus thrombosis (n=52). Anticoagulation and/or surgical thrombectomy was evaluated on Clinical outcomes and management strategies. Anticoagulation remains the cornerstone of treatment for coronary sinus thrombosis, with surgical thrombectomy reserved for severe or refractory cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: